Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.20%2.08B | -3.66%6.05B | -2.65%4.6B | -5.79%3.45B | -4.11%2.08B | -0.82%6.28B | -2.16%4.72B | 2.94%3.66B | 0.95%2.17B | 9.00%6.34B |
| Special items of operating revenue | 23.25%26.36M | ---- | -6.89%62.87M | ---- | -11.87%21.39M | ---- | -7.05%67.52M | ---- | -0.46%24.27M | ---- |
| Operating income | 0.44%2.11B | -3.66%6.05B | -2.71%4.66B | -5.79%3.45B | -4.20%2.1B | -0.82%6.28B | -2.23%4.79B | 2.94%3.66B | 0.93%2.19B | 9.00%6.34B |
| Cost of sales | ---- | 3.86%-5.17B | ---- | 8.60%-2.78B | ---- | 0.50%-5.38B | ---- | -2.92%-3.04B | ---- | -7.65%-5.41B |
| Operating expenses | 0.71%-1.79B | 3.86%-5.17B | 4.80%-3.74B | 8.60%-2.78B | 3.44%-1.8B | 0.50%-5.38B | 2.90%-3.93B | -2.92%-3.04B | -0.60%-1.86B | -7.65%-5.41B |
| Special items of gross profit | -23.25%-26.36M | ---- | 6.89%-62.87M | ---- | 11.87%-21.39M | ---- | 7.05%-67.52M | ---- | 0.46%-24.27M | ---- |
| Gross profit | 6.13%295.19M | -2.44%883.51M | 8.01%854.75M | 7.96%671.71M | -8.23%278.15M | -2.69%905.58M | 1.67%791.34M | 3.03%622.2M | 3.18%303.11M | 17.55%930.64M |
| Selling expenses | -6.70%-61.96M | 0.36%-195.84M | -4.94%-189.68M | -7.05%-122.25M | -0.11%-58.07M | 3.31%-196.55M | 2.84%-180.75M | 8.84%-114.19M | -28.22%-58.01M | -1.90%-203.29M |
| Administrative expenses | 0.70%-72.67M | -6.84%-549.07M | 4.07%-301.14M | 13.98%-190.5M | 8.66%-73.18M | 1.00%-513.9M | 18.48%-313.93M | -18.88%-221.47M | 27.39%-80.12M | -28.90%-519.08M |
| Research and development expenses | 0.00%-231.13K | ---- | -200.00%-693.4K | ---- | ---231.13K | ---- | 10.91%-231.13K | ---- | ---- | ---- |
| Profit from asset sales | -1,408.16%-174.45K | ---- | 2,583.61%4.22M | ---- | -81.69%13.34K | ---- | -142.16%-169.82K | ---- | 1,352.74%72.82K | ---- |
| Revaluation surplus | -360.06%-30.87M | ---- | -1,082.89%-269.05M | ---- | 327.92%11.87M | ---- | 87.19%-22.74M | ---- | 86.57%-5.21M | ---- |
| -Changes in the fair value of other assets | -360.06%-30.87M | ---- | -1,082.89%-269.05M | ---- | 327.92%11.87M | ---- | 87.19%-22.74M | ---- | 86.57%-5.21M | ---- |
| Impairment and provision | 116.95%464.08K | 425.58%5.08M | -957.61%-20.49M | 44.65%-1.13M | 5.29%-2.74M | 94.34%-1.56M | -48.02%2.39M | -191.39%-2.04M | -77.08%-2.89M | 69.23%-27.54M |
| -Other impairment is provision | 116.95%464.08K | 425.58%5.08M | -957.61%-20.49M | 44.65%-1.13M | 5.29%-2.74M | 94.34%-1.56M | -48.02%2.39M | -191.39%-2.04M | -77.08%-2.89M | 69.23%-27.54M |
| Special items of operating profit | -56.22%70.7M | -11.02%171.5M | 197.92%781.64M | -32.36%64.42M | 670.36%161.5M | -7.63%192.73M | -50.49%262.37M | 6.50%95.24M | -93.69%20.96M | -12.11%208.64M |
| Operating profit | -37.55%193.96M | -18.41%315.19M | 61.84%842.12M | 11.20%422.26M | 81.86%310.59M | -0.79%386.3M | -4.86%520.33M | -1.10%379.73M | -59.69%170.79M | 15.41%389.38M |
| Financing income | -13.21%25.67M | ---- | -14.47%58M | ---- | -11.46%29.57M | ---- | 14.51%67.81M | ---- | 89.14%33.4M | ---- |
| Financing cost | 16.82%-46.34M | 21.65%-202.15M | 18.65%-159.83M | 18.49%-107.47M | 18.62%-55.71M | 12.44%-258.02M | 16.10%-196.47M | 18.34%-131.85M | 14.01%-68.46M | 9.74%-294.69M |
| Share of profits of associates | ---- | 224.82%660.99M | ---- | 1,379.51%420.09M | ---- | -37.23%203.49M | ---- | -94.74%28.39M | ---- | 10,494.80%324.2M |
| Share of profit from joint venture company | ---- | 186.04%11.24M | ---- | ---- | ---- | -125.47%-13.06M | ---- | ---- | ---- | -29.29%51.29M |
| Special items of earning before tax | 0.57%220.01K | -267.83%-194.7M | -56.43%374.02K | -548.04%-225.57M | -42.89%218.75K | 272.38%116.01M | -95.21%858.42K | 141.96%50.35M | -66.44%383.03K | 82.56%-67.3M |
| Earning before tax | -46.55%150.97M | 35.85%590.57M | 91.70%723.64M | 55.94%509.31M | 104.11%282.45M | 7.90%434.72M | -12.21%377.48M | -49.13%326.62M | -59.89%138.38M | 234.52%402.88M |
| Tax | ---- | 17.03%-88.19M | ---- | 15.50%-82.93M | ---- | -7.10%-106.29M | ---- | -32.18%-98.14M | ---- | -318.52%-99.25M |
| After-tax profit from continuing operations | -56.21%105.25M | 52.97%502.38M | 123.73%626.56M | 86.62%426.39M | 185.78%240.36M | 8.16%328.43M | -23.87%280.05M | -59.76%228.48M | -72.28%84.11M | 219.51%303.64M |
| Earning after tax | -56.21%105.25M | 52.97%502.38M | 123.73%626.56M | 86.62%426.39M | 185.78%240.36M | 8.16%328.43M | -23.87%280.05M | -59.76%228.48M | -72.28%84.11M | 219.51%303.64M |
| Minority profit | 17.68%54.42M | -8.47%87.21M | -2.66%106.79M | -12.19%93.37M | -18.05%46.24M | 4.60%95.28M | 15.90%109.71M | 17.78%106.33M | 29.30%56.43M | 16.01%91.09M |
| Profit attributable to shareholders | -73.82%50.83M | 78.07%415.17M | 205.14%519.77M | 172.62%333.02M | 601.27%194.12M | 9.69%233.15M | -37.65%170.34M | -74.42%122.16M | -89.34%27.68M | 163.91%212.54M |
| Basic earnings per share | -71.43%0.02 | 75.00%0.14 | 200.00%0.18 | 175.00%0.11 | 644.68%0.07 | 14.29%0.08 | -33.33%0.06 | -75.00%0.04 | -89.32%0.0094 | 163.64%0.07 |
| Diluted earnings per share | -71.43%0.02 | 75.00%0.14 | 200.00%0.18 | 175.00%0.11 | 644.68%0.07 | 14.29%0.08 | -33.33%0.06 | -75.00%0.04 | -89.32%0.0094 | 163.64%0.07 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.